• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A centennial review of discoveries and advances in diabetes: Children and youth.糖尿病百年回顾:儿童与青少年。
Pediatr Diabetes. 2022 Nov;23(7):926-943. doi: 10.1111/pedi.13392. Epub 2022 Sep 4.
2
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
3
Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.持续葡萄糖监测在青少年起病的2型糖尿病中的应用。
Curr Diab Rep. 2017 Sep;17(9):66. doi: 10.1007/s11892-017-0905-0.
4
Leveraging advances in diabetes technologies in primary care: a narrative review.利用初级保健中的糖尿病技术进步:叙述性评论。
Ann Med. 2021 Dec;53(1):805-816. doi: 10.1080/07853890.2021.1931427.
5
Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy.儿科 1 型糖尿病:技术对合并症和预期寿命的影响及其作用机制。
Int J Mol Sci. 2023 Jul 26;24(15):11980. doi: 10.3390/ijms241511980.
6
Current management of diabetes mellitus and future directions in care.糖尿病的当前管理及护理的未来方向。
Postgrad Med J. 2015 Nov;91(1081):612-21. doi: 10.1136/postgradmedj-2014-133200. Epub 2015 Oct 9.
7
Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.1型糖尿病血糖连续监测:一项卫生技术评估
Ont Health Technol Assess Ser. 2018 Feb 21;18(2):1-160. eCollection 2018.
8
Technological Developments and Quality of Life in Type 1 Diabetes Mellitus Patients: A Review of the Modern Insulin Analogues, Continuous Glucose Monitoring and Insulin Pump Therapy.1 型糖尿病患者的技术发展与生活质量:现代胰岛素类似物、连续血糖监测和胰岛素泵治疗的综述。
Curr Diabetes Rev. 2022;18(7):e031121197657. doi: 10.2174/1573399818666211103163208.
9
Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.个人连续血糖监测在糖尿病管理中的应用:文献综述与实际应用。
Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28.
10

引用本文的文献

1
Pediatric Endocrinology Education Among Trainees: A Scoping Review.实习生的儿科内分泌学教育:一项范围综述
Clin Teach. 2025 Feb;22(1):e70011. doi: 10.1111/tct.70011.
2
Efficacy of the hybrid closedloop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis.混合闭环胰岛素输送系统在儿童和青少年 1 型糖尿病患者中的疗效:一项荟萃分析与试验序贯分析。
Arch Endocrinol Metab. 2024 Apr 11;68:e230280. doi: 10.20945/2359-4292-2023-0280.
3
Sequential data mining of infection patterns as predictors for onset of type 1 diabetes in genetically at-risk individuals.对感染模式进行序列数据挖掘,以预测遗传易感个体 1 型糖尿病的发病。
J Biomed Inform. 2023 Jun;142:104385. doi: 10.1016/j.jbi.2023.104385. Epub 2023 May 9.

本文引用的文献

1
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.2020 年 3 月 1 日至 2021 年 6 月 28 日期间,年龄<18 岁的 SARS-CoV-2 感染者在新冠病毒感染后 30 天以上新发糖尿病的风险。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
2
U300 Insulin Glargine: A Novel Basal Insulin for Type 1 and Type 2 Diabetes.U300甘精胰岛素:一种用于1型和2型糖尿病的新型基础胰岛素。
J Pharm Technol. 2015 Oct;31(5):234-242. doi: 10.1177/8755122515584193. Epub 2015 Apr 29.
3
COVID-19, Hyperglycemia, and New-Onset Diabetes.新型冠状病毒肺炎、高血糖和新发糖尿病。
Diabetes Care. 2021 Dec;44(12):2645-2655. doi: 10.2337/dc21-1318. Epub 2021 Oct 8.
4
Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative.1型糖尿病儿童和成人健康结局的不平等:来自T1D交换质量改进协作组的数据。
Clin Diabetes. 2021 Jul;39(3):278-283. doi: 10.2337/cd21-0028.
5
One hundred years of insulin therapy.胰岛素治疗的百年历程。
Nat Rev Endocrinol. 2021 Dec;17(12):715-725. doi: 10.1038/s41574-021-00542-w. Epub 2021 Aug 17.
6
100 years on: the impact of the discovery of insulin on clinical outcomes.100 年过去了:胰岛素发现对临床结果的影响。
BMJ Open Diabetes Res Care. 2021 Aug;9(1). doi: 10.1136/bmjdrc-2021-002373.
7
Long-Term Complications in Youth-Onset Type 2 Diabetes.青少年 2 型糖尿病的长期并发症。
N Engl J Med. 2021 Jul 29;385(5):416-426. doi: 10.1056/NEJMoa2100165.
8
100 years of insulin: celebrating the past, present and future of diabetes therapy.胰岛素百年:庆祝糖尿病治疗的过去、现在和未来。
Nat Med. 2021 Jul;27(7):1154-1164. doi: 10.1038/s41591-021-01418-2. Epub 2021 Jul 15.
9
Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications.营养与肥胖在青年起病 1 型糖尿病及其并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2021 Mar 22;12:622901. doi: 10.3389/fendo.2021.622901. eCollection 2021.
10
The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes.SWEET 项目在全球 19 个国家开展的 10 年基准研究显示,其与改善青少年 1 型糖尿病患者的糖化血红蛋白水平和增加糖尿病技术的使用有关。
Diabetes Technol Ther. 2021 Jul;23(7):491-499. doi: 10.1089/dia.2020.0618. Epub 2021 Feb 26.

糖尿病百年回顾:儿童与青少年。

A centennial review of discoveries and advances in diabetes: Children and youth.

机构信息

Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.

Division of Pediatric Endocrinology, Baystate Children's Hospital - UMASS Chan Medical School - Baystate, Springfield, Massachusetts, USA.

出版信息

Pediatr Diabetes. 2022 Nov;23(7):926-943. doi: 10.1111/pedi.13392. Epub 2022 Sep 4.

DOI:10.1111/pedi.13392
PMID:35821595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219647/
Abstract

Diabetes is an increasingly common chronic metabolic disorder in children worldwide. The discovery of insulin in 1921 resulted in unprecedented advancements that improved the lives of children and youth with diabetes. The purpose of this article is to review the history of diabetes in children and youth over the last century and its implications for future developments in the field. We identified 68 relevant events between 1921 and 2021 through literature review and survey of pediatric endocrinologists. Basic research milestones led to the discovery of insulin and other regulatory hormones, established the normal physiology of carbohydrate metabolism and pathophysiology of diabetes, and provided insight into strategies for diabetes prevention. While landmark clinical studies were initially focused on adult diabetes populations, later studies assessed etiologic factors in birth cohort studies, evaluated technology use among children with diabetes, and investigated pharmacologic management of youth type 2 diabetes. Technological innovations culminated in the introduction of continuous glucose monitoring that enabled semi-automated insulin delivery systems. Finally, professional organizations collaborated with patient groups to advocate for the needs of children with diabetes and their families. Together, these advances transformed type 1 diabetes from a terminal illness to a manageable disease with near-normal life expectancy and increased our knowledge of type 2 diabetes and other forms of diabetes in the pediatric population. However, disparities in access to insulin, diabetes technology, education, and care support remain and disproportionately impact minority youth and communities with less resources. The overarching goal of diabetes management remains promoting a high quality of life and improving glycemic management without undermining the psychological health of children and youth living with diabetes.

摘要

糖尿病是一种在全球范围内日益普遍的儿童慢性代谢性疾病。1921 年胰岛素的发现带来了前所未有的进步,改善了儿童和青少年糖尿病患者的生活。本文的目的是回顾过去一个世纪儿童和青少年糖尿病的历史及其对该领域未来发展的影响。我们通过文献回顾和对儿科内分泌学家的调查,确定了 1921 年至 2021 年期间的 68 项相关事件。基础研究的里程碑导致了胰岛素和其他调节激素的发现,确立了碳水化合物代谢的正常生理学和糖尿病的病理生理学,并为糖尿病预防策略提供了深入了解。虽然里程碑式的临床研究最初侧重于成人糖尿病人群,但后来的研究在出生队列研究中评估了病因因素,评估了儿童糖尿病患者的技术使用情况,并研究了青少年 2 型糖尿病的药物管理。技术创新最终导致了连续血糖监测的引入,从而实现了半自动胰岛素输送系统。最后,专业组织与患者团体合作,倡导满足糖尿病儿童及其家庭的需求。这些进展共同将 1 型糖尿病从一种绝症转变为一种可管理的疾病,使患者接近正常的预期寿命,并增加了我们对儿科人群中 2 型糖尿病和其他形式糖尿病的了解。然而,获得胰岛素、糖尿病技术、教育和护理支持的机会仍然存在差距,并且不成比例地影响到资源较少的少数族裔青年和社区。糖尿病管理的总体目标仍然是在不损害患有糖尿病的儿童和青少年的心理健康的情况下,促进高质量的生活并改善血糖管理。